Vitamin D status and supplementation in morbid obesity before and after bariatric surgery

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 6, 2010, Pages 781-794

  Bacci, Vincenzo ^a   Silecchia, Gianfranco ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

bariatric surgery; biliopancreatic diversion; calcium; gastric banding; gastric bypass; morbid obesity; nutrition; parathyroid hormone; sleeve gastrectomy; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; BONE TURNOVER; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; GASTRECTOMY; GASTRIC BANDING; HIGH RISK PATIENT; HORMONAL REGULATION; HUMAN; IMMUNOREGULATION; JEJUNOILEAL BYPASS; LOW DRUG DOSE; MALABSORPTION; MORBID OBESITY; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

BARIATRIC SURGERY; CALCIUM; DIETARY SUPPLEMENTS; HUMANS; OBESITY, MORBID; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78649670045     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.69     Document Type: Review

References (80)

1. Bikle D. Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 94, 26-34 (2009).
2. 2+)](i) and insulin release. Evidence obtained from calbindin-D(28k) knockout mice and cell lines. J. Biol. Chem. 274, 34343-34349 (1999).
3. Pittas AG, Lau J, Hu FB et al. The role of vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92, 2017-2029 (2007). (Pubitemid 46997093)
4. Kulie T, Groff A, Redmer J, Hounshell J, Schrager S. Vitamin D: an evidence-based review. J. Am. Board. Fam. Med. 22(6), 698-706 (2009).
5. Liu E, Meigs JB, Pittas AG et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J. Nutr. 39(2), 329-334 (2009).
6. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 87(1), 136-141 (2008).
7. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol. 102, 1540-1544 (2008).
8. Chapuy MC, Preziosi P, Maamer M et al Prevalence of vitamin D insuffciency in an adult normal population. Osteoporos. Int. 7, 439-443 (1997).
9. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84(1), 18-28 (2006).
10. Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am. J. Clin. Nutr. 79, 717-726 (2004).
11. Vieth R, Bischoff-Ferrari H, Boucher BJ et al. The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85, 649-650 (2007).
12. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. 19(2), 73-78 (2009).
13. Schweiger C, Weiss R, Berry E, Keidar A. Nutritional defciencies in bariatric surgery candidates. Obes. Surg. 20(2), 193-197 (2010).
14. Snijder MB, van Dam RM, Visser M et al Adiposity in relation to vitamin d status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 90, 4119-4123 (2005).
15. Looker AC. Body fat and vitamin D status in black versus white women. J. Clin. Endocrinol. Metab. 90(2), 635-640 (2005).
16. Kremer R, Campbell PP, Reinhardt T, Gilsanz V Vitamin D status and its relationship to body fat, fnal height, and peak bone mass in young women. J. Clin. Endocrinol. Metab. 94(1), 67-73 (2009).
17. Young KA, Engelman CD, Langefeld CD et al. Association of plasma vitamin D levels with adiposity in Hispanic and African-Americans. J. Clin. Endocrinol Metab. 94(9), 3306-3313 (2009).
18. Lenders CM, Feldman HA, Von Scheven E et al. Relation of body fat indexes to vitamin D status and defciency among obese adolescents. Am. J. Clin. Nutr. 90(3), 459-467 (2009).
19. Stein M, Strain G, Sinha N. Vitamin D insuffciency prior to bariatric surgery: risk factors and a pilot treatment study. Clin. Endocrinol. 71(2), 176-183 (2009).
20. Parker J, Hashmi O, Dutton D et al. Levels of vitamin D and cardiometabolic disorders: systematic review and metaanalysis. Maturitas 65(3), 225-236 (2010).
21. Rueda S, Fernández-Fernández C, Romero F, Martínez de Osaba MJ, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes. Surg. 18, 151-154 (2008).
22. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 72(3), 690-693 (2000).
23. Gomez-Ambrosi J, Rodriguez A, Catalan V, Fruhbeck G. The bone-adipose axis in obesity and weight loss. Obes. Surg 18, 1134-1143 (2008).
24. Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion? J. Gastrointest. Surg. 6, 690-698 (2002).
25. Davies DJ, Baxter JM, Baxter JN. Nutritional defciencies after bariatric surgery. Obes. Surg 17, 1150-1158 (2007).
26. Compher CW, Badellino KO, Boullata JI. Vitamin D and the bariatric surgical patient: a review. Obes. Surg 18, 220-224 (2008).
27. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes. Surg 13(3), 383-388 (2003).
28. Olmos JM, Vázquez LA, Amado JA, Hernández JL, González Macías J. Mineral metabolism in obese patients following vertical banded gastroplasty. Obes. Surg 18(2), 197-203 (2008).
29. di Giorgi M, Daud A, Inabnet WB et al Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes. Surg 18(9), 1144-1148 (2008).
30. Pugnale N, Giusti V, Suter M et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int. J. Obes. 27, 110-116 (2003).
31. Ledoux S, Msika S, Moussa F et al. Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes. Surg 16, 1041-1049 (2006).
32. Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes. Surg 16(11), 1445-1449 (2006).
33. Lee C, Hamoui N, Anthone G, Kaufman HS, Crookes PF. Calcium homeostasis after bariatric surgery: a comparison of the sleeve gastrectomy, duodenal switch, and Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 3, 283 (2007).
34. Abu-Jaish W, Ramirez A, Patel S et al. Prevalence of nutritional defciencies after laparoscopic sleeve gastrectomy as a fnal step in morbidly obese patients. Surg. Obes. Relat. Dis. 5(3), S53 (2009).
35. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient defciencies in bariatric patients. Nutrition 25, 1150-1156 (2009).
36. Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient defciencies after laparoscopic sleeve gastrectomy then after laparoscopic Roux-Y-gastric bypass-a prospective study. Obes. Surg 20(4), 447-453 (2010).
37. Mechanick JI, Kushner RF, Sugerman HJ et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes. Relat. Dis. 4(5 Suppl.), S109-S184 (2008).
38. Tadross JA, le Roux CW. The mechanisms of weight loss after bariatric surgery. Int. J. Obes. 33, S28-S32 (2009).
39. Vage V, Gjesdal CG, Eide GE, Halse JI, Viste A. Bone mineral density in females after jejunoileal bypass: a 25-year follow-up study. Obes. Surg 14(3), 305-312 (2004).
40. Singh D, Laya AS, Carkston WK, Allen MJ. Jejunoileal bypass: a surgery of the past and a review of its complications. World J. Gastroenterol. 15(18), 2277-2279 (2009).
41. Chapin BL, LeMar HJ Jr, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch. Surg 131(10), 1048-1052 (2006).
42. Scopinaro N, Marinari G, Camerini G, Papadia F. 2004 ABS Consensus Conference. Biliopancreatic diversion for obesity: state of the art. Surg Obes. Relat. Dis. 1(3), 317-328 (2005).
43. Bloomberg RD, Fleishman A, Nalle JE. Nutritional defciencies following bariatric surgery: what have we learned? Obes. Surg 15, 145-154 (2005).
44. Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes. Surg 13(6), 893-895 (2003).
45. Moreiro J, Ruiz O, Perez G et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes. Surg 17, 348-354 (2007).
46. Lozano O, García-Díaz JD, Cancer E. Phosphocalcic metabolism after biliopancreatic diversion. Obes. Surg. 17, 642-648 (2007).
47. Balsa JA, Botella-Carretero JI, Peromingo R et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J. Endocrinol Invest. 31(10), 845-850 (2008).
48. Marceau P, Biron S, Hould FS et al. Duodenal switch: long-term results. Obes. Surg 17(11), 1421-1430 (2007).
49. Tsiftsis DD, Mylonas P, Mead N, Kalfarentzos F, Alexandrides TK. Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss? Obes. Surg 19, 1497-1503 (2009).
50. Aasheim ET, Björkman S, Søvik TT et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am. J. Clin. Nutr. 90(1), 15-22 (2009).
51. Marceau P, Biron S, Hould FS et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg. Obes. Relat. Dis. 5(1), 43-47 (2009).
52. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg. Obes. Relat. Dis. 5(3), 387-405 (2009).
53. Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity 14(11), 1940-1948 (2006).
54. Jin J, Robinson AV, Hallowell PT, Jasper JJ, Stellato TA, Wilhem SM. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery 142(6), 914-920 (2007).
55. Pradhan KR, Larson CJ, Mathiason MA et al. Calcium, parathormone, and vitamin D abnormalities among Roux-en-Y gastric bypass patients. Bariat. Nurs. Surg. Pat. 3(3), 205-209 (2008).
56. Carlin AM, Rao DS, Yager KM, Genaw JA, Parikh NJ, Szymanski W. Effect of gastric bypass surgery on vitamin D nutritional status. Surg. Obes. Relat. Dis. 2(6), 638-642 (2006).
57. Valderas JP, Velasco S, Solari S et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes. Surg. 19(8), 1132-1138 (2009).
58. Youssef Y, Richards WO, Sekhar N et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg. Endosc. 21(8), 1393-1396 (2007).
59. Johnson JJ, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann. Surg. 243(5), 701-705 (2006).
60. Jin J, Stellato TA, Hallowell PT, Schuster M, Graf K, Wilhelm S. Utilization of preoperative patient factors to predict postoperative vitamin D defciency for patients undergoing gastric bypass. J. Gastrointest. Surg. 13, 1052-1057 (2009).
61. Vilarrasa N, Gómez JM, Elio I et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes. Surg. 19, 860-866 (2009).
62. Mahdy T, Atia S, Farid M, Adulatif A. Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes. Surg. 18, 1526-1531 (2008).
63. Signori C, Zalesin K Wendy MM et al. Correction of preoperative vitamin D defciency after Roux-en-Y gastric bypass surgery. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery 142(6), 914-920 (2007).
64. Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional defciencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am. J. Clin. Nutr. 87(5), 1128-1133 (2008).
65. Johnson JM, Maher JW, de Maria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann. Surg. 243(5), 701-704 (2006).
66. Duran de Campos C, Dalcanale L, Pajecki D, Garrido AB Jr, Halpern A. Calcium intake and metabolic bone disease after eight years of Roux-en-Y gastric bypass. Obes. Surg. 18, 386-390 (2008).
67. Dalcanale L, Oliveira CPMS, Faintuch J et al. Long-term nutritional outcome after gastric bypass. Obes. Surg. 20, 2, 181-187 (2010).
68. Nelson ML, Bolduc LM, Toder ME, Clough DM, Sullivan SS. Correction of preoperative vitamin D defciency after Roux-en-Y gastric bypass surgery. Surg. Obes. Relat. Dis. 3(4), 434-437 (2007).
69. Srikanth MS, Quddusi S, Fox SR, Oh KH et al. Correction of secondary hyperparathyroidism after distal gastric bypass using oral high dose vitamin D, calcitriol and calcium replacement. Surg. Obes. Relat. Dis. 1, 271 (2005).
70. Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg. Obes. Relat. Dis. 5, 444-449 (2009).
71. Goldner WS, Stoner JA, Lyden E et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes. Surg 19(2), 173-179 (2009).
72. Fried M, Hainer V, Basdevant A et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int. J. Obes. 31, 569-577 (2007). (Pubitemid 46482359)
73. Aills L, Blankenship J, Buffngton C, Furtado M, Parrot J. ASMBS Allied Health Nutritional guidelines for the Surgical Weight Loss Patient Surg Obes. Relat. Dis. 4, S73-S108 (2008).
74. Clay TD, Cohen L, Preen DB. Once yearly 'megadose' intramuscular vitamin D (600,000 IU): a simple, safe and effective method to normalize vitamin D levels after BPD surgery. Surg Obes. Relat. Dis. 3, 353-357 (2007).
75. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J. Gastrointest. Surg. 10(7), 1033-1037 (2006).
76. Goldner WS, Stoner JA, Thompson J et al. Prevalence of vitamin D insuffciency and defciency in morbidly obese patients: a comparison with non-obese controls. Obes. Surg. 18(2), 145-150 (2008).
77. Gemmel K, Santry HP, Prachand VN, Alverdy J. Vitamin D defciency in preoperative bariatric surgery patients Surg. Obes. Relat. Dis. 5, 54-59 (2009).
78. Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P. Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int. J. Obes. 29(12), 1429-1435 (2005).
79. Pradham KR, Larson CJ, Mathiason MA et al. Calcium, parathormone and vitamin D abnormalities among Roux-en-Y gastric bypass patients. Surg. Obes. Relat. Dis. 2(3), 357 (2006).
80. Signori C, Zalesin K, Wendy MM et al. The effect of gastric bypass on vitamin D Surg. Obes. Relat. Dis. 4, 334 (2008).